Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

Hélène Salmon, Miriam Mérad, Joshua Brody et al.|Immunity|2016

Cited by 1.2k